Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 24

    1.

    Regulation of matrix synthesis, remodeling and accumulation in glomerulosclerosis.

    Pozzi A, Voziyan PA, Hudson BG, Zent R.

    Curr Pharm Des. 2009;15(12):1318-33. Review.PMID: 19355971 [PubMed - indexed for MEDLINE]Related articles

    2.

    Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine.

    Chetyrkin SV, Mathis ME, Ham AJ, Hachey DL, Hudson BG, Voziyan PA.

    Free Radic Biol Med. 2008 Apr 1;44(7):1276-85. Epub 2007 Oct 4.PMID: 18374270 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of pyridoxamine.

    Chetyrkin SV, Zhang W, Hudson BG, Serianni AS, Voziyan PA.

    Biochemistry. 2008 Jan 22;47(3):997-1006. Epub 2007 Dec 28.PMID: 18161948 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.

    Davies SS, Brantley EJ, Voziyan PA, Amarnath V, Zagol-Ikapitte I, Boutaud O, Hudson BG, Oates JA, Roberts LJ 2nd.

    Biochemistry. 2006 Dec 26;45(51):15756-67. Epub 2006 Dec 6.PMID: 17176098 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.

    Scheinman JI, Voziyan PA, Belmont JM, Chetyrkin SV, Kim D, Hudson BG.

    Urol Res. 2005 Nov;33(5):368-71. Epub 2005 Nov 15. Erratum in: Urol Res. 2006 Feb;34(1):67. PMID: 16292584 [PubMed - indexed for MEDLINE]Related articles

    6.

    Designing a high throughput refolding array using a combination of the GroEL chaperonin and osmolytes.

    Voziyan PA, Johnston M, Chao A, Bomhoff G, Fisher MT.

    J Struct Funct Genomics. 2005;6(2-3):183-8.PMID: 16211517 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy.

    Pedchenko VK, Chetyrkin SV, Chuang P, Ham AJ, Saleem MA, Mathieson PW, Hudson BG, Voziyan PA.

    Diabetes. 2005 Oct;54(10):2952-60.PMID: 16186398 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pyridoxamine: the many virtues of a maillard reaction inhibitor.

    Voziyan PA, Hudson BG.

    Ann N Y Acad Sci. 2005 Jun;1043:807-16. Review.PMID: 16037308 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.

    Voziyan PA, Hudson BG.

    Cell Mol Life Sci. 2005 Aug;62(15):1671-81. Review.PMID: 15905958 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.

    Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA.

    Kidney Int. 2005 Jan;67(1):53-60.PMID: 15610227 [PubMed - indexed for MEDLINE]Related articles

    11.

    Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.

    Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG.

    J Biol Chem. 2003 Nov 21;278(47):46616-24. Epub 2003 Sep 15.PMID: 12975371 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Polyols induce ATP-independent folding of GroEL-bound bacterial glutamine synthetase.

    Voziyan PA, Fisher MT.

    Arch Biochem Biophys. 2002 Jan 15;397(2):293-7.PMID: 11795885 [PubMed - indexed for MEDLINE]Related articles

    13.

    A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.

    Voziyan PA, Metz TO, Baynes JW, Hudson BG.

    J Biol Chem. 2002 Feb 1;277(5):3397-403. Epub 2001 Nov 29.PMID: 11729198 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Refolding a glutamine synthetase truncation mutant in vitro: identifying superior conditions using a combination of chaperonins and osmolytes.

    Voziyan PA, Jadhav L, Fisher MT.

    J Pharm Sci. 2000 Aug;89(8):1036-45.PMID: 10906727 [PubMed - indexed for MEDLINE]Related articles

    16.

    Partitioning of rhodanese onto GroEL. Chaperonin binds a reversibly oxidized form derived from the native protein.

    Smith KE, Voziyan PA, Fisher MT.

    J Biol Chem. 1998 Oct 30;273(44):28677-81.PMID: 9786862 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Changing the nature of the initial chaperonin capture complex influences the substrate folding efficiency.

    Voziyan PA, Tieman BC, Low CM, Fisher MT.

    J Biol Chem. 1998 Sep 25;273(39):25073-8.PMID: 9737964 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The C-terminus of phosphatidylinositol transfer protein modulates membrane interactions and transfer activity but not phospholipid binding.

    Tremblay JM, Voziyan PA, Helmkamp GM Jr, Yarbrough LR.

    Biochim Biophys Acta. 1998 Jan 15;1389(2):91-100.PMID: 9461250 [PubMed - indexed for MEDLINE]Related articles

    19.

    Importance of phospholipid in the folding and conformation of phosphatidylinositol transfer protein: comparison of apo and holo species.

    Voziyan PA, Tremblay JM, Yarbrough LR, Helmkamp GM Jr.

    Biochemistry. 1997 Aug 19;36(33):10082-8.PMID: 9254603 [PubMed - indexed for MEDLINE]Related articles

    20.

    Truncations of the C-terminus have different effects on the conformation and activity of phosphatidylinositol transfer protein.

    Voziyan PA, Tremblay JM, Yarbrough LR, Helmkamp GM Jr.

    Biochemistry. 1996 Sep 24;35(38):12526-31.PMID: 8823189 [PubMed - indexed for MEDLINE]Related articles

    21.

    Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesol-induced apoptotic cell death.

    Voziyan PA, Haug JS, Melnykovych G.

    Biochem Biophys Res Commun. 1995 Jul 17;212(2):479-86.PMID: 7626062 [PubMed - indexed for MEDLINE]Related articles

    22.

    Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine.

    Haug JS, Goldner CM, Yazlovitskaya EM, Voziyan PA, Melnykovych G.

    Biochim Biophys Acta. 1994 Aug 11;1223(1):133-40.PMID: 8061045 [PubMed - indexed for MEDLINE]Related articles

    23.

    Differences in sensitivity to farnesol toxicity between neoplastically- and non-neoplastically-derived cells in culture.

    Adany I, Yazlovitskaya EM, Haug JS, Voziyan PA, Melnykovych G.

    Cancer Lett. 1994 May 16;79(2):175-9.PMID: 8019976 [PubMed - indexed for MEDLINE]Related articles

    24.

    Farnesol inhibits phosphatidylcholine biosynthesis in cultured cells by decreasing cholinephosphotransferase activity.

    Voziyan PA, Goldner CM, Melnykovych G.

    Biochem J. 1993 Nov 1;295 ( Pt 3):757-62.PMID: 8240288 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...